| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | MS1J9720WC |
Pharmacology
| Action | Mechanism of Action | Reference | |
|---|---|---|---|
| ANTAGONIST | Hepatocyte growth factor receptor antagonist | PubMed |
| Primary Target | |
|---|---|
| MET proto-oncogene, receptor tyrosine kinase |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference | ||
|---|---|---|---|---|---|
| Neoplasms | 3 | D009369 | ClinicalTrials | ||
| Neoplasms | 3 | D009369 | ClinicalTrials | ||
| Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials | ||
| Stomach Neoplasms | 3 | D013274 | ClinicalTrials | ||
| Breast Neoplasms | 2 | D001943 | ClinicalTrials | ||
| Colorectal Neoplasms | 2 | D015179 | ClinicalTrials | ||
| Glioblastoma | 2 | D005909 | ClinicalTrials | ||
| Lung Neoplasms | 1 | D008175 | ClinicalTrials | ||
| Carcinoma, Hepatocellular | 1 | D006528 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1133766-06-9 |
| ChEMBL | CHEMBL1743051 |
| FDA SRS | MS1J9720WC |
| Guide to Pharmacology | 8966 |
CONTENTS